BioBusiness.TV |

BioSpecifics Technologies Corp. 60sec Pitch

BioSpecifics Technologies Corp. 60sec Pitch Thomas L. Wegman, President Website: http://www.biospecifics.com/ Company Overview BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed and licensed injectable collagenase for three clinical indications: Dupuytren's disease, Peyronie's disease and frozen shoulder (adhesive capsulitis). It has a development and licensing agreement with Auxilium Pharmaceuticals, Inc. Positive top line results from the Phase III clinical trials ...

Novelos Therapeutics, Inc. 60sec Pitch

Novelos Therapeutics, Inc. 60sec Pitch Harry S. Palmin, President and Chief Executive Officer Website: http://www.novelos.com/ Company Overview Novelos Therapeutics, Inc. is a biopharmaceutical company commercializing oxidized glutathione-based compounds for the treatment of cancer and hepatitis. NOV-002, the lead compound currently in Phase 3 development for lung cancer under a SPA and Fast Track, acts together with chemotherapy as a chemoprotectant and ...

Delcath Systems, Inc. 60sec Pitch

Delcath Systems, Inc. 60sec Pitch Richard L. Taney, President and Chief Executive Officer Website: http://www.delcath.com/ Company Overview Delcath Systems, Inc. is a medical technology company specializing in cancer treatment. The Company has developed a proprietary, patented system which will improve the efficacy of cancer treatment while reducing the considerable, systemic side-effects of chemotherapy. The Company is currently enrolling patients in Phase ...

Antigenics Inc. 60sec Pitch

Antigenics Inc. 60sec Pitch Garo H. Armen, PhD, Chairman and Chief Executive Officer Website: http://www.antigenics.com/ Company Overview Antigenics is a biotechnology company working to develop treatments for cancers and infectious diseases. The company’s investigational product portfolio includes Oncophage® (vitespen), a patient-specific therapeutic cancer vaccine being evaluated in several indications; QS-21 Stimulon®, an adjuvant being evaluated by Antigenics’ collaborative partners in approximately ...

Agile Therapeutics, Inc. 60sec Pitch

Agile Therapeutics, Inc. 60sec Pitch Thomas M. Rossi, PhD, President and Chief Executive Officer Website: http://www.agiletherapeutics.com/ Company Overview Agile Therapeutics is a specialty pharmaceutical company focused on developing and commercializing innovative women’s healthcare products that address unmet needs. Agile was founded in 1997 and is headquartered in Princeton, New Jersey. The Company’s lead product is a low dose, once-weekly contraceptive patch ...

Alchemia Limited, 60sec Pitch

Alchemia Limited, 60sec Pitch Pete Smith, PhD, Chief Executive Officer Website: http://www.alchemia.com.au/ Company Overview Alchemia is an Australian biopharmaceutical company employing innovative technologies for the synthesis of complex carbohydrates, the targeting of cancer drugs to tumors and the discovery of medicinal drugs for human use. Alchemia’s portfolio includes the antithrombotic drug fondaparinux (due for market launch in 2009), the anticancer drug ...

Stem Cell Therapeutics Corp. 60sec Pitch

Stem Cell Therapeutics Corp. 60sec Pitch Alan Moore, PhD, President and Chief Executive Officer Website: http://www.stemcellthera.com/ Company Overview Stem Cell Therapeutics Corp. is a Canadian biotechnology company (TSX-V: SSS) focused on the development and commercialization of drug-based therapies to treat central nervous system diseases. SCT is a leader in the development of therapies that utilize drugs to stimulate a patient's own ...

Akela Pharma Inc. 60sec Pitch

Akela Pharma Inc. 60sec Pitch Halvor Jaeger, MD FCP, Chief Executive Officer Website: http://www.akelapharma.com/ Company Overview AKELA Pharma Inc. (TSX: AKL) is an integrated drug development company focused on developing therapies for the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting fentanyl formulation, delivered using the company’s approved TAIFUN® dry powder ...

Antisoma PLC, 60sec Pitch

Antisoma PLC, 60sec Pitch Daniel Elger, PhD, Director of Communications Website: http://www.antisoma.com/ **Company Overview** Antisoma is an oncology-focused biotech company with operations in the UK and the US. Antisoma’s strategy is to acquire promising early-stage drug candidates, develop these through clinical trials, and bring them to market itself or through partnerships. Recent Developments Antisoma recently acquired Cambridge MA-based Xanthus Pharmaceuticals Inc., and now ...

Arana Therapeutics, Inc. 60sec Pitch

Arana Therapeutics, Inc. 60sec Pitch Steffen Nock, PhD, President, US Operations Website: http://www.arana.com/ **Company Overview** Arana Therapeutics Limited, created through the merger of Peptech Limited and EvoGenix Limited in August 2007, is a biotechnology company dedicated to developing and providing antibody and peptide-based human therapeutic products for the treatment of cancer and inflammatory diseases. The company has tapped its unique antibody ...